Pharmacists, as well as patients, are now able to quickly obtain details of clinical trials for new medicines in development via a new Web site established by the pharmaceutical industry. This Internet site, www.ifpma.org/ clinicaltrials, provides detailed information about most, but not all, clinical studies under way by the global pharmaceutical industry. By making this information more easily accessible to the public, drugmakers hope to allay consumer concerns over the safety of new pharmaceuticals.
Those concerns spiked earlier this year following the withdrawal of Vioxx and disclosures of serious side effects associated with other pain medications on the market. Created by the International Federation of Pharmaceutical Manufacturers and Associations, the new Web site is designed to enable patients to learn about opportunities to participate in clinical trials for drugs being studied to treat their conditions.
Mr. Rankin is a freelance medical writer.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs